Keyphrases
Induction Chemotherapy
44%
Severe Hypoglycemia
44%
Glargine U100
44%
Type I Diabetes
44%
Venetoclax
44%
Type 1 Diabetes Mellitus (T1DM)
44%
Insulin Degludec
44%
Relapsed or Refractory Acute Myeloid Leukemia
44%
Treatment Comparison
44%
Multiple Thromboses
44%
ChAdOx1 nCoV-19
44%
Insulin Glargine
44%
Attack Risk
44%
CD26
44%
Thrombocytopenia
44%
Epidermal Growth Factor Receptor
44%
Tumor Expression
44%
Multiple Sclerosis
44%
Non-myeloablative Transplantation
44%
Interferon-α (IFN-α)
44%
Oral Cancer
44%
Osteoporosis
44%
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
44%
Expression Pattern
44%
Vaccination
44%
Cerebral Toxoplasmosis
44%
Prognostic Value
44%
Outpatient Clinic
44%
COVID-19
44%
In Care
44%
CD4 Count
44%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
44%
Graft-versus-host Disease (GvHD)
44%
Red Blood Cell Transfusion
44%
General Practitioners
44%
Platelets
44%
Tissue Factor
44%
Interferon-β (IFN-β)
33%
Insulin Glargine U100
29%
Hematological Malignancies
29%
RBC Transfusion
26%
Platelet Transfusion
26%
Salvage Treatment
22%
Primary Adherence
22%
Relative Rate
22%
Rate Reduction
22%
Asymptomatic Hypoglycemia
22%
Storage Time
22%
Prothrombin mutation
22%
Portal Vein Thrombosis
22%
Medicine and Dentistry
Neoplasm
100%
Plasmacytoid Dendritic Cell
44%
Erythrocyte Transfusion
44%
Epidermal Growth Factor Receptor
44%
Erythrocyte
44%
Urokinase Receptor
44%
Cell Transplantation
44%
Oral Cancer
44%
Cerebral Toxoplasmosis
44%
Hematopoietic Stem Cell
44%
Acute Graft Versus Host Disease
44%
Venetoclax
44%
Platelet
44%
Thromboplastin
44%
Induction Chemotherapy
44%
Acute Myeloid Leukemia
44%
Thrombocytopenia
44%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
Thrombosis
44%
Biological Marker
24%
Hematologic Malignancy
22%
Overall Survival
22%
Oral Contraceptive Agent
22%
Heparin-Induced Thrombocytopenia
22%
Prothrombin
22%
Hazard Ratio
17%
Mouth Squamous Cell Carcinoma
16%
Minimal Residual Disease
14%
Blood Donor
13%
Specific Tumor
12%
Receptor Expression
12%
Differential Diagnosis
11%
Symptom
11%
Skin Defect
11%
Ecchymosis
11%
Heparin Platelet Factor 4 Antibody
11%
Central Nervous System
11%
Thrombotic Thrombocytopenic Purpura
11%
Immunoassay
11%
Cerebral Sinus Thrombosis
11%
Disseminated Intravascular Coagulation
11%
Awareness
11%
Diagnosis
11%
Disease Predisposition
11%
Adenoviridae
11%
Autoimmune Disease
11%
Heterozygosity
11%
Phlebothrombosis
11%
Portal Vein Thrombosis
11%
Infection
11%
